Partnerships
Porsolt and KWS BioTest combined forces to provide comprehensive preclinical evaluation in the area of inflammation and immunology. The partnership enables Porsolt and KWS to deliver a complete cascade of tests to evaluate drug candidates, from simple screening assays to more complex models with high translational value. The combination of the expertise of skilled teams of scientists working in both companies provides customers with integrated solutions for highly efficient discovery and development of their drug candidates in these important therapeutic domains with large unmet needs.
Porsolt & Partners Pharmacology is an independent Contract Research Organization. As a niche CRO, they specialize in animal pharmacology, and have developed a wide range of test procedures and models in laboratory animals for evaluating the Efficacy and Safety of human and veterinary drug candidates. They have industry-recognized models for a number of CNS indications, including anxiety, depression, schizophrenia, cerebral trauma, stroke, age related memory disorders, Parkinson’s disease and migraine.
To find out more visit their website via the link below:
The partnership between KWS BioTest and Quotient Bioresearch enables the two companies to provide high quality screening of anti-infectives all the way from in vitro activity assays, efficacy and resistance profiling through validated models of human disease to clinical investigations, with full scientific support.
Quotient is a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide. Their innovative range of services are provided on a standalone basis, or integrated, to deliver bespoke development programmes.
To find out more visit their website via the link below: